Key Highlights

  • AMN Healthcare Services (NYSE:AMN) shares are up 95.63% over six months and 13.07% over three months, per published market data on October 7, 2026, with a market cap near USD 1.40 billion.
  • Second quarter Revenue was USD 673.2 million, up 2% year over year, while adjusted EBITDA rose 26% to USD 73.4 million, according to the company release dated August 6, 2026.
  • Third quarter guidance calls for revenue of USD 640 million to USD 655 million and an adjusted EBITDA Margin of 6.5% to 7.0%, which implies growth of 1% to 3% year over year.
  • The stock trades on a published P/E of 13.5 at USD 36.25, and labor disruption work added USD 25 million of second quarter revenue, a point investors are weighing carefully.

What AMN Reported on August 6, 2026

AMN Healthcare announced second quarter 2026 results on August 6, 2026. Revenue of USD 673.2 million rose 2% from a year earlier. Net Income was USD 21.2 million, or USD 0.53 per diluted share on a GAAP basis, and adjusted Diluted Earnings per Share were USD 0.77. Adjusted EBITDA of USD 73.4 million was 26% higher than the prior year period. The company said travel nurse and allied volumes grew for a second straight quarter, and search revenue climbed 27%. Chief executive Cary Grace pointed to year over year growth in travel nurse, international nurse, allied, schools and search solutions. The release also noted two small acquisitions, Jaide Health and the ESSENTIAL Leadership Assessment, which add artificial intelligence and advisory capability.

Why the Numbers Move the Shares

AMN supplies temporary clinicians to hospitals, so revenue depends on how many shifts clients need filled and the bill rates they pay. After several years of shrinking demand, two quarters of rising travel nurse and allied volumes suggest the cycle may be stabilising. Profit moves faster than revenue because staffing costs are largely variable, which helps explain why adjusted EBITDA grew 26% on 2% revenue growth. The company also reported USD 362 million of cash against USD 750 million of total debt, a Leverage Ratio of 1.5 times. That Balance Sheet gives management room to invest. Published market data shows the share price at USD 36.25, with a P/E of 13.5 and a market cap of about USD 1.40 billion.

Risks and What to Watch

The quality of the rebound is the main question. Labor disruption work, typically temporary coverage during strikes, contributed USD 25 million of second quarter revenue, and that kind of Demand can disappear as quickly as it arrives. Third quarter guidance of USD 640 million to USD 655 million sits below the second quarter level of USD 673.2 million, so the sequential trend is lower even though year over year growth of 1% to 3% is expected. Hospital budgets, bill rates and any Medicaid or reimbursement pressure on provider clients also matter. The share price is up sharply, and it slipped 1.31% on October 7, 2026. The third quarter report, which has no confirmed date in the verified material, is the next test.

Where Things Stand

AMN Healthcare (NYSE:AMN) is up 95.6% in six months because two quarters of rising nurse and allied volumes, a 26% jump in adjusted EBITDA and a clean balance sheet have changed the narrative from decline to recovery. Published market data shows a P/E of 13.5, which still looks modest. Yet guidance points to a lower third quarter than the second, and strike related revenue may not repeat. This article is informational and is not Investment advice.